The Vanguard Group, Inc. has recently announced that it has increased stake in Jaguar Health Inc (NASDAQ:JAGX) by 142.35%. After grabbing 0.19 million shares, the institutional investor is now in possession of 0.11 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.38% having worth around $68087.0. Moreover, JPMorgan Securities LLC increased its share by 62401.0 to have a control over 85384.0 shares. And Sterling Investment Advisors Ltd. raised its holdings to 20000.0 shares by acquiring 39000.0 shares or 0.08% of the stake.
Jaguar Health Inc (JAGX) concluded trading on 12/27/23 at a closing price of $0.16, with 3.68 million shares of worth about $0.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -68.53% during that period and on Wednesday the price saw a loss of about -4.96%. Currently the company’s common shares owned by public are about 50.76M shares, out of which, 45.35M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 25 times over the past 12 months. They bought 1,380,182 shares in 25 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Fidelity Extended Market Index Fu, Vanguard Extended Market Index Fu, and Fidelity Total Market Index Fund are the top 3 mutual funds which are holding stakes in Jaguar Health Inc Fidelity Extended Market Index Fu is currently holding 0.34 million shares of worth totaling $0.12 million. The company recently came buying 0.25 million shares which brought its stake up to 0.67% of the company’s outstanding shares. Fidelity Total Market Index Fund, after buying 854.0 shares, have now control over 0.00% of the stake in the company. It holds 0.0 shares of worth $302.0.
However, the stock later moved at a day high price of 0.1720, or with a loss of -4.96%. Stock saw a price change of 0.62% in past 5 days and over the past one month there was a price change of -53.39%. Year-to-date (YTD), JAGX shares are showing a performance of -97.50% which decreased to -97.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.15 but also hit the highest price of $9.15 during that period. The average intraday trading volume for Jaguar Health Inc shares is 6.32 million. The stock is currently trading -31.87% below its 20-day simple moving average (SMA20), while that difference is down -45.63% for SMA50 and it goes to -66.94% lower than SMA200.
The Vanguard Group, Inc. acquired 0.19 million shares of Jaguar Health Inc having value of about $68087.0. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 0.11 million shares in the company valued at close to $18075.84, or have control over 142.35% stake in the company. Jaguar Health Inc (NASDAQ: JAGX) currently have 50.76M outstanding shares and institutions hold larger chunk of about 1.16% of that. Holding of mutual funds in the company is about 1.06% while other institutional holders and individual stake holders have control over 2.76% and 0.10% of the stake respectively.
The stock has a current market capitalization of $8.27M and its 3Y-monthly beta is at 1.44. It has posted earnings per share of -$6.88 in the same period. It has Quick Ratio of 1.10 while making debt-to-equity ratio of 26.13. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for JAGX, volatility over the week remained 6.72% while standing at 11.73% over the month.
Analysts are in expectations that Jaguar Health Inc (JAGX) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$9 in the same quarter a year ago. EPS is likely to shrink at an annualized rate of 40.00% for next 5-years, compared to annual growth of 80.25% made by the stock over the past 5-years.
Analysts at 1 brokerage firms have issued recommendations for the Jaguar Health Inc (JAGX)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on July 07, 2021 offering an Overweight rating for the stock and assigned a target price of $5 to it.
